Semisynthesis, hydrolytic stability, photophysical properties, and antioxidant capacity of a betalain derived from mefenamic acid
Diphenylamine derivatives are used as nonsteroidal anti-inflammatory drugs due to their ability to prevent prostaglandin biosynthesis by inhibiting the activity of cyclooxygenases COX-1 and COX-2. Despite their therapeutic effectiveness, the use of these drugs is limited by their side effects in the gastrointestinal tract, which leads to the search for therapeutic alternatives for a variety of inflammatory diseases. Betalains are non-toxic pigments found in plants and fungi that interfere in the pro-inflammatory signaling cascade, mainly in the nuclear factor kappa B (NF-κB) pathway. This Master's Thesis describes the semisynthesis of a betalain derived from the coupling between betalamic acid and mefenamic acid, a commercial diphenylamine used as a nonsteroidal anti-inflammatory agent. The compound obtained, called MefBeet, had its photophysical characterization, hydrolytic stability, antioxidant capacity and interaction with proteins determined, presenting characteristics that lead the molecule to be a possible candidate for the development of an anti-inflammatory drug. MefBeet is soluble in water and its hydrolysis does not depend on the pH in the range from 3 to 7. Its maximum absorption in water is 502 nm and its excitation at this wavelength produces an emission centered at 567 nm (Stoke shift: 65 nm, 2284 cm–1). Although the quantum fluorescence yield in the solution is low (ΦFL = 5.5 × 10–3), it was observed that its interaction with an excesso of 100 equiv. of bovine serum albumin (BSA) results in an 40-70× increase in the fluorescence quantum yield, which is not pH dependent in the range between 5 and 7. Furthermore, it was observed that MefBeet has a greater antiradical capacity than Trolox and the precursor amine itself (1.6×). The results may contribute to the development of anti-inflammatory drugs with combined action obtained from natural products.